Novavax, Inc. (NASDAQ:NVAX) rose over 11% on Tuesday after it declared a number of promotions within its clinical operations group in preparation for expanded clinical trial activities in 2014 and 2015. Novavax, Inc. (NASDAQ:NVAX), stock opened at $6.14 in last session, and closed at $5.73, while the day range of NVAX stock is $5.00 – $6.15. The stock showed a negative weekly performance of -6.53%.
Geron Corporation (NASDAQ:GERN) tumbled more than 18 percent in the current trading session after the biopharmaceutical company reported that enrollment had stopped in an early stage test of drug for the treatment of blood cancer. Geron Corporation (NASDAQ:GERN), stock opened at $5.04, in last session and closed at $4.76, by losing -15.30%. The 52 week range of GERN is $0.98 – $7.79. Company’s market capitalization is $613.88million.
MannKind Corporation (NASDAQ:MNKD) shares increased 0.54% to $5.59. The company on Jan. 10 announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is tentatively scheduled on April 1, 2014 to review MannKind’s New Drug Application (NDA) for AFREZZA(R) (insulin human [rDNA origin]) Inhalation Powder. MannKind Corporation (NASDAQ:MNKD), stock decreased -5.77% and finished the last session at $5.23. The EPS of the stock remained -0.71. Company’s market capitalization is $1.87billion.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), stock opened the session at $1.05, and closed the session at $1.02. The 52 week range of the RNN stock remained $0.28 – $1.85 and the day range was $0.95 – $1.05.